🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study purpose is to examine whether there are structural or functional ...
Status
Completed
Location
University of Minnesota
Start Date
2015-07-01
Trial ID
NCT02861820
Treatments Being Tested
This phase II clinical trial is studying how well selumetinib works in trea...
Status
Terminated
Location
Northwestern University
Start Date
2010-12
Trial ID
NCT01278615
Treatments Being Tested
This partially randomized phase I/II trial studies the side effects and bes...
Status
Completed
Location
Mayo Clinic
Start Date
2016-04
Trial ID
NCT02492750
Treatments Being Tested
The purpose of this study is to assess whether Multiple Sclerosis patients ...
Status
Unknown
Location
MS Center at Evergreen Health
Start Date
2013-01
Trial ID
NCT01811290
This randomized phase II trial studies how well cisplatin with or without W...
Status
Terminated
Location
Juravinski Cancer Centre at Hamilton Health Sciences
Start Date
2014-03
Trial ID
NCT02196168
Treatments Being Tested
Approximately 2% of neonates in the US are born very preterm. Preterm birth...
Status
Terminated
Location
Jack D. Weiler Hospital
Start Date
2015-04
Trial ID
NCT02557191
Treatments Being Tested
Primary objective: * To identify a biomarker or biomarker-set for the adve...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00971724
Treatments Being Tested
This is a research study looking at whether the way people speak can help p...
Status
Enrolling By Invitation
Location
Acacia Clinics
Start Date
2025-02-18
Trial ID
NCT06823024
The overall objective of this study is to determine the feasibility of iden...
Status
Recruiting
Location
University of Minnesota
Start Date
2022-04-11
Trial ID
NCT04864080
Treatments Being Tested
This is an open label, single centre, phase II study of neoadjuvant drug tr...
Status
Completed
Location
Melanoma Institute Australia
Start Date
2014-10-01
Trial ID
NCT01972347
Treatments Being Tested